erectile dysfunction
Conditions
Interventions
experimental group:patients treated with low intensity shock waves
control group:The procedure used in the control group was the same as that of the treatment group. But the equipment probe did not emit a shock wave during treatment, only the sound was the same as th
Sponsors
The first affiliated Hospital of Guangzhou medical University
Eligibility
Sex/Gender
Male
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Age 30-60 years, male; 2. Overall health; 3. Accord with vascular erectile dysfunction (ED), diabetes-induced erectile dysfunction (ED); 4. Have a history of ED at least 6 months and no more than 7 years; 5. Effective for phosphodiesterase 5 inhibitors (PDE5-i) previously; 6. No PDE5-i treatment within 4 weeks before grouping; 7. International index of erectile function (IIEF-5) score between 5 and 21 points; 8. Stable heterosexual relationships at least 3 months before treatment; 9. Subjects voluntarily agree to participate in this trial and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Hormonal, neurological or psychopathological factors for ED; 2. patients who had radical prostatectomy or pelvic surgery before; 3. Any unstable medical, psychiatric, spinal cord injury, penile anatomical abnormality, excessive obesity; 4. Patients with penile prosthesis; 5. Patients who have recovered from cancer in the past year or who have serious illnesses of vital organs; 6. Serious hematonosis; 7. Venous leakage; 8. Poor blood pressure control (systolic blood pressure =160mmHg and diastolic blood pressure =100mmHg after treatment); 9. Poor glycemic control, fasting plasma glucose (FPG) levels> 7.0 mmol / l (126 mg / dl) after treatment; 10. Anti-androgen, oral or inject androgen; 11. After pelvic radiotherapy; 12. Coagulation dysfunction or the use of anticoagulants (such as coumarin Coumadin); 13. Participated in any other medical device or drug clinical investigator in the past three months; 14. Other investigators who are considered not suitable in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International index of erectile function 5;EHS;Colour Doppler ultrasonography of the penile; | — |
Secondary
| Measure | Time frame |
|---|---|
| SEP;GAQ; | — |
Countries
China
Contacts
Public ContactZhigang Zhao
The first affiliated Hospital of Guangzhou medical University
Outcome results
None listed